PXXLF
Price:
$0.25
Market Cap:
$21.40M
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is Imeglimin, an oral drug candidate, which completed Phase III clinical development stage in Japan, as well as in Phase III in the United States and Europe for the treatment of type 2 diabetes that improves pancreatic beta cell function, reduces insulin resistance, and decreases cardiovascular and metabolic disease risk factors, such as heightened blood lipid levels and excess body weight. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats c...[Read more]
Industry
Biotechnology
IPO Date
2017-01-06
Stock Exchange
OTC
Ticker
PXXLF
According to Poxel S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 87.45M. This represents a change of 73.24% compared to the average of 50.48M of the last 4 quarters.
The mean historical Enterprise Value of Poxel S.A. over the last ten years is 124.73M. The current 87.45M Enterprise Value has changed 6.91% with respect to the historical average. Over the past ten years (40 quarters), PXXLF's Enterprise Value was at its highest in in the December 2019 quarter at 287.01M. The Enterprise Value was at its lowest in in the June 2011 quarter at 0.
Average
124.73M
Median
101.64M
Minimum
57.71M
Maximum
286.87M
Discovering the peaks and valleys of Poxel S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 288.21%
Maximum Annual Enterprise Value = 286.87M
Minimum Annual Increase = -59.83%
Minimum Annual Enterprise Value = 57.71M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 72.67M | 10.17% |
| 2023 | 65.96M | 14.29% |
| 2022 | 57.71M | -59.83% |
| 2021 | 143.66M | -9.36% |
| 2020 | 158.50M | -44.75% |
| 2019 | 286.87M | 288.21% |
| 2018 | 73.90M | -26.94% |
| 2017 | 101.14M | -0.98% |
| 2016 | 102.14M | -44.71% |
| 2015 | 184.72M | 52.85% |
The current Enterprise Value of Poxel S.A. (PXXLF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
65.45M
5-year avg
99.70M
10-year avg
124.73M
Poxel S.A.’s Enterprise Value is greater than Eiger BioPharmaceuticals, Inc. (28.35M), greater than Ceapro Inc. (-5906285.00), greater than Noxopharm Limited (23.43M), greater than Rapid Dose Therapeutics Corp. (24.93M), greater than Progressive Care, Inc. (7.44M), less than Titan Medical Inc. (88.71M), greater than Bionomics Limited (-6089290.00), greater than Living Cell Technologies Limited (21.43M), less than Sorrento Therapeutics, Inc. (112.25M), less than American Hemp Ventures, Inc. (0),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 28.35M | $12.59M | |
| -5906285.00 | $13.31M | |
| 23.43M | $14.78M | |
| 24.93M | $10.10M | |
| 7.44M | $13.49M | |
| 88.71M | $13.91M | |
| -6089290.00 | $8.81M | |
| 21.43M | $11.39M | |
| 112.25M | $16.54M | |
| 0 | $16.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poxel S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poxel S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Poxel S.A.'s Enterprise Value?
What is the highest Enterprise Value for Poxel S.A. (PXXLF)?
What is the 3-year average Enterprise Value for Poxel S.A. (PXXLF)?
What is the 5-year average Enterprise Value for Poxel S.A. (PXXLF)?
How does the current Enterprise Value for Poxel S.A. (PXXLF) compare to its historical average?